Also trades as: ERIS.BO (BSE) · $vol 0M
ERIS.NS NSE
Eris Lifesciences Limited
1W: -6.7%
1M: -8.5%
3M: -16.9%
YTD: -18.8%
1Y: -29.0%
3Y: +49.5%
5Y: +61.9%
₹1,190.80 ($12.38)
-1.10 (-0.09%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹165.0B ($1.7B)
52W Range1162.9-1740
Volume88,725
Avg Volume85,370
Beta-0.04
Dividend₹7.21
Analyst Ratings
No analyst coverage
Company Info
CEOAmit Indubhushan Bakshi
Employees2,758
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-06-30
Websiteeris.co.in
Shivarth Ambit
Ahmedabad, GU 380054
IN
Ahmedabad, GU 380054
IN
91 79 6966 1000
About Eris Lifesciences Limited
Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found